ArticlePloS one2026
A qualitative study of same session co-use of nicotine and cannabis among adolescents and young adults.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Understanding commercial tobacco and Cannabis co-use in American Indian young adults in California.Addictive behaviors reports · 2026Article
- Patterns in methods, timing, and sequence of nicotine and cannabis co-use among adolescents.Drug and alcohol dependence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeNicotine and cannabis are commonly co-used among adolescents and young adults (AYAs). Same session co-use has more negative effects than co-use that does not overlap. Little is known about how or why these products are used within the same session. Enhanced understanding of this behavior pattern can be leveraged to reduce co-use in this population.
methodsConnecticut AYAs (15-20 years old) who self-reported past-month nicotine and cannabis vaping participated in 1-hour focus groups examining of nicotine and cannabis use. Six focus groups were conducted in Spring 2023 (N = 29, mean group size n = 5). Data was analyzed with a two-stage deductive and inductive approach.
resultsParticipants reported deliberate same session use in various modes (e.g., smoking, vaping). Same session use was most commonly reported to enhance positive psychoactive effects of cannabis (e.g., improve/enhance the high). Other common reasons were to reduce negative cannabis effects, such as vaping nicotine to reduce throat irritation or mask taste (e.g., vaping flavored nicotine product to mask cannabis taste). Some reported vaping nicotine so frequently that it unintentionally overlapped with cannabis use. Finally, other participants reported avoiding same session use as the combined psychoactive effects of nicotine and cannabis were too strong.
conclusionAYAs reported same session use primarily to enhance cannabis use experience (e.g., improving high or taste, reducing negative effects). Our findings indicate a complementary role of nicotine and cannabis, and suggest that prevention and cessation efforts for either substance need to address co-use behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.